StockData
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31

KYNTRA BIO, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.28+0.43 (+8.87%)

Close on Oct 19, 2026

Market cap
$21.37M
P/E (TTM)
0.1
Dividend yield
–

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
24.7%
1M of 4M shares
Institutional holders
27
1 new, 5 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
4 buys · 0 sales
Net bought $73.45K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Steven Boyd8,500,0008.42%13G (passive) amendmentMar 31, 2025
Armistice Capital, LLC400,0009.88%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of KYNBValueChange% of portfolio
Armistice Capital, LLC400,0009.88%$3.02M–0.04%
Vanguard Capital Management LLC159,9503.95%$1.21M+3,3430.00%
Acadian Asset Management LLC105,5852.61%$795–0.00%
BlackRock, Inc.84,3302.08%$636.69K−10.00%
Geode Capital Management, LLC43,2191.07%$326.39K−2,7790.00%
HighTower Advisors, LLC39,7460.98%$300.08K+20.00%
Two Sigma Investments, LP39,5110.98%$298.31K−10,0000.00%
Renaissance Technologies LLC27,0810.67%$204.46K−4000.00%
Vanguard Fiduciary Trust Co24,1050.60%$181.99K+1630.00%
Birchview Capital, LP22,5660.56%$170.37K–0.08%
State Street Corp20,2840.50%$153.14K–0.00%
Gsa Capital Partners Llp15,6970.39%$119New0.01%
UBS Group AG7,8570.19%$59.32K−19,7340.00%
Group One Trading, L.P.4,4060.11%$33.27K−860.00%
Vanguard Global Advisers, LLC1,4240.04%$10.75K–0.00%
Tower Research Capital LLC (TRC)1,1130.03%$8.40K+7810.00%
Axiom Investment Management LLC7040.02%$5.32K–0.00%
Morgan Stanley4870.01%$3.68K−10.00%
Harbour Investments, Inc.2000.00%$1.51K–0.00%
National Bank Of Canada /Fi/1930.00%$1.45K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026271M24.7%1 / 68 / 50M0M
Q1 2026321M25.6%8 / 58 / 80M0M
Q4 2025341M28.7%6 / 810 / 40M0M
Q3 2025321M28.0%4 / 98 / 10M0M
Q2 2025291M25.8%29 / 00 / 01M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of KYNBValue% of fundAs of
Vanguard Total Stock Market Index Fund114,1792.82%$862.05K0.00%Jun 30, 2026
Vanguard Extended Market Index Fund42,2651.04%$319.10K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund21,0790.52%$145.45K0.00%May 31, 2026
Fidelity Total Market Index Fund7,0050.17%$48.33K0.00%May 31, 2026
Fidelity Series Total Market Index Fund5,7440.14%$39.63K0.00%May 31, 2026
Vanguard Balanced Index Fund3,5060.09%$26.47K0.00%Jun 30, 2026
Vanguard Capital Opportunity Fund2,7160.07%$20.51K0.00%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund1,9910.05%$13.74K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund1850.00%$1.40K0.00%Jun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND220.00%$1470.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Thane WettigCEO, Director26,8360.66%Sep 9, 2026
David DeLuciaChief Financial Officer4,3550.11%Sep 9, 2026
Christine ChungSVP, CHINA OPERATIONS294,5447.27%Mar 7, 2025
Juan GrahamCHIEF FINANCIAL OFFICER164,8634.07%Dec 9, 2024
Maykin HoDirector37,7260.93%Jun 17, 2026
Michael KauffmanDirector––Jun 17, 2026
James A. SchoeneckDirector68,4321.69%Jun 17, 2026
Jeffrey L. EdwardsDirector38,6010.95%Jun 17, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Thane Wettig
CEO, Director
Sep 6, 2026Tax withholding−209$8.55$1.79K26,796
David DeLucia
Chief Financial Officer
Sep 6, 2026Tax withholding−22$8.55$1884,355
David DeLucia
Chief Financial Officer
Jun 6, 2026Tax withholding−52$6.71$3494,377
Thane Wettig
CEO, Director
Jun 6, 2026Tax withholding−198$6.71$1.33K27,005
Thane Wettig
CEO, Director
May 14, 2026Buy+2,800$7.09$19.85K27,203
Thane Wettig
CEO, Director
May 14, 2026Buy−2,800$7.09$19.85K27,203
Thane Wettig
CEO, Director
Mar 6, 2026Tax withholding−277$6.84$1.89K24,403
David DeLucia
Chief Financial Officer
Mar 6, 2026Tax withholding−60$6.84$4104,429
David DeLucia
Chief Financial Officer
Dec 6, 2025Tax withholding−52$8.42$4384,489
Thane Wettig
CEO, Director
Dec 6, 2025Tax withholding−259$8.42$2.18K24,680
Thane Wettig
CEO, Director
Nov 17, 2025Buy+2,700$9.10$24.57K24,939
Thane Wettig
CEO, Director
Nov 13, 2025Buy+1,000$9.18$9.18K22,239
David DeLucia
Chief Financial Officer
Sep 6, 2025Tax withholding−53$12.10$6414,541
Thane Wettig
CEO, Director
Sep 6, 2025Tax withholding−248$12.10$3.00K21,239
James A. Schoeneck
Director
Jun 30, 2025Buy+23,567$5.07$119.48K39,666
David DeLucia
Chief Financial Officer
Jun 6, 2025Tax withholding−51$7.83$3994,594
Thane Wettig
CEO, Director
Jun 6, 2025Tax withholding−246$7.83$1.93K21,487
Thane Wettig
CEO, Director
Mar 24, 2025Buy+145,000$0.35$50.75K543,329
James A. Schoeneck
Director
Mar 21, 2025Buy+50,000$0.34$17.00K373,722
James A. Schoeneck
Director
Mar 20, 2025Buy+250,000$0.35$87.50K323,722
David DeLucia
Chief Financial Officer
Mar 6, 2025Tax withholding−2,325$0.39$907116,137
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2025Tax withholding−7,008$0.39$2.73K294,544
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2025Tax withholding−422$0.39$165294,903
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2025Award+781––295,325
Thane Wettig
CEO, Director
Mar 6, 2025Tax withholding−22,038$0.39$8.59K397,915
Thane Wettig
CEO, Director
Mar 6, 2025Tax withholding−367$0.39$143398,329
Thane Wettig
CEO, Director
Mar 6, 2025Award+781––398,696
Juan Graham
CHIEF FINANCIAL OFFICER
Dec 7, 2024Tax withholding−1,066$0.34$362164,863
Juan Graham
CHIEF FINANCIAL OFFICER
Dec 6, 2024Tax withholding−1,446$0.34$492165,929
Christine Chung
SVP, CHINA OPERATIONS
Dec 6, 2024Tax withholding−2,792$0.34$949301,552
Thane Wettig
CEO, Director
Dec 6, 2024Tax withholding−2,363$0.34$803419,953
Juan Graham
CHIEF FINANCIAL OFFICER
Sep 7, 2024Tax withholding−1,065$0.39$415167,375
Christine Chung
SVP, CHINA OPERATIONS
Sep 6, 2024Tax withholding−17,395$0.39$6.78K304,344
Juan Graham
CHIEF FINANCIAL OFFICER
Sep 6, 2024Tax withholding−16,050$0.39$6.26K168,440
Thane Wettig
CEO, Director
Sep 6, 2024Tax withholding−2,363$0.39$922422,316
Thane Wettig
CEO, Director
Aug 1, 2024Tax withholding−20,840$0.47$9.79K424,679
Thane Wettig
CEO, Director
Jun 22, 2024Tax withholding−782$1.13$884445,519
Deyaa Adib
Chief Medical Officer
Jun 12, 2024Buy+22,123$1.17$25.88K82,123
Juan Graham
CHIEF FINANCIAL OFFICER
Jun 7, 2024Tax withholding−1,182$1.10$1.30K184,490
Juan Graham
CHIEF FINANCIAL OFFICER
Jun 6, 2024Tax withholding−17,797$1.19$21.18K185,672
Christine Chung
SVP, CHINA OPERATIONS
Jun 6, 2024Tax withholding−19,289$1.19$22.95K321,739
Thane Wettig
CEO, Director
Jun 6, 2024Tax withholding−2,255$1.19$2.68K446,301
Thane Wettig
CEO, Director
May 1, 2024Tax withholding−20,840$1.17$24.38K448,556
Thane Wettig
CEO, Director
Mar 22, 2024Tax withholding−782$2.58$2.02K469,396
Thane Wettig
CEO
Mar 7, 2024Buy+50,000$1.91$95.50K470,178
Juan Graham
CHIEF FINANCIAL OFFICER
Mar 7, 2024Tax withholding−1,181$1.79$2.11K203,469
Thane Wettig
CEO
Mar 6, 2024Tax withholding−4,209$1.87$7.87K419,723
Thane Wettig
CEO
Mar 6, 2024Award+781––420,504
Thane Wettig
CEO
Mar 6, 2024Tax withholding−326$1.87$610420,178
Juan Graham
CHIEF FINANCIAL OFFICER
Mar 6, 2024Tax withholding−20,327$1.87$38.01K204,291
Juan Graham
CHIEF FINANCIAL OFFICER
Mar 6, 2024Award+781––205,072
Juan Graham
CHIEF FINANCIAL OFFICER
Mar 6, 2024Tax withholding−422$1.87$789204,650
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2024Tax withholding−422$1.87$789341,028
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2024Tax withholding−23,168$1.87$43.32K340,669
Christine Chung
SVP, CHINA OPERATIONS
Mar 6, 2024Award+781––341,450
Christine Chung
SVP, CHINA OPERATIONS
Feb 21, 2024Award+29,000––363,837
Thane Wettig
CEO
Feb 21, 2024Award+166,000––423,932
Juan Graham
CHIEF FINANCIAL OFFICER
Feb 21, 2024Award+52,000––224,618
Thane Wettig
CEO
Feb 1, 2024Tax withholding−23,490$2.37$55.67K257,932
Thane Wettig
CEO
Dec 22, 2023Tax withholding−819$0.76$622281,422

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Henderson Jeffrey
Director
Sep 1, 20232,000$2.12KSep 1, 2023Acquired as compensation -- Restricted Stock Units
Henderson Jeffrey
Director
Aug 4, 20232,000$3.82KAug 4, 2023Acquired as compensation -- Restricted Stock Units
Henderson Jeffrey
Director
Jul 11, 20232,000$5.46KJul 11, 2023Acquired as compensation -- Restricted Stock Units
Thane Wettig
Officer
Jun 23, 2023791$13.07KJun 23, 2023RESTRICTED STOCK
Chung Christine
Officer
Jun 13, 202362,500$1.10MJun 13, 2023Compensation-- Restricted Stock Units
Cravatt Benjamin
Director
Jun 9, 20233,944$67.72KJun 9, 2023Restricted Stock
Blaug Suzanne
Director
Jun 9, 20238,520$146.55KJun 9, 2023Restricted Stock
L. Edwards Jeffrey
Director
Jun 9, 20237,889$135.61KJun 9, 2023Restricted Stock
Brennan Aoife
Director
Jun 9, 20234,733$81.36KJun 9, 2023Restricted Stock
Henderson Jeffrey
Director
Jun 8, 20237,000$124.46KJun 8, 2023Acquired as compensation -- Restricted Stock Units
Juan Graham
Officer
Jun 8, 20231,050$17.80KJun 8, 2023RESTRICTED STOCK
Ho May-Kin
Director
Jun 8, 20238,520$151.49KJun 8, 2023Acquired as compensation -- Restricted Stock Units
Thane Wettig
Officer
Jun 7, 20231,758$29.95KJun 7, 2023RESTRICTED STOCK
Juan Graham
Officer
Jun 7, 20231,406$23.96KJun 7, 2023RESTRICTED STOCK
James A. Schoeneck
Director
Jun 7, 20237,100$127.99KJun 7, 2023RSU Vest